UBS Group AG - VIRIOS THERAPEUTICS INC ownership

VIRIOS THERAPEUTICS INC's ticker is VIRI and the CUSIP is 92829J104. A total of 29 filers reported holding VIRIOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VIRIOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$366
-39.0%
265
-83.8%
0.00%
Q1 2023$600
-96.2%
1,636
-96.0%
0.00%
Q3 2022$16,000
-74.6%
41,041
+190.3%
0.00%
Q1 2022$63,000
+425.0%
14,137
+528.3%
0.00%
Q4 2021$12,000
-85.7%
2,250
-83.1%
0.00%
Q2 2021$84,000
+236.0%
13,316
+300.8%
0.00%
Q4 2020$25,0003,3220.00%
Other shareholders
VIRIOS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 80,590$30,664,0000.12%
Warberg Asset Management LLC 200,000$74,0000.01%
Koshinski Asset Management, Inc. 40,924$16,0000.00%
&PARTNERS 11,000$4,0000.00%
Virtu Financial LLC 47,765$18,0000.00%
Walleye Capital LLC 150,000$57,0000.00%
UBS Group AG 41,041$16,0000.00%
OSAIC HOLDINGS, INC. 8,621$3,0000.00%
WELLS FARGO & COMPANY/MN 48$00.00%
NORTHERN TRUST CORP 15,836$6,0000.00%
View complete list of VIRIOS THERAPEUTICS INC shareholders